Related references
Note: Only part of the references are listed.Novel Molecular Targets for Hepatocellular Carcinoma
Beatrice Cavalluzzo et al.
CANCERS (2022)
Molecular mimicry between tumor associated antigens and microbiota-derived epitopes
Concetta Ragone et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2022)
Oncogenic activity and cellular functionality of melanoma associated antigen A3
Paula Schaefer et al.
BIOCHEMICAL PHARMACOLOGY (2021)
Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discovery
Shin-Heng Chiou et al.
IMMUNITY (2021)
Identification and validation of viral antigens sharing sequence and structural homology with tumor-associated antigens (TAAs).
Concetta Ragone et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
The tumor microenvironment
Nicole M. Anderson et al.
CURRENT BIOLOGY (2020)
Selecting Target Antigens for Cancer Vaccine Development
Luigi Buonaguro et al.
VACCINES (2020)
Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage
Aurelie Fluckiger et al.
SCIENCE (2020)
Cancer Neoantigens
Ton N. Schumacher et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 37, 2019 (2019)
Methods for improving the immunogenicity and efficacy of cancer vaccines
Lorenzo Pilla et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2018)
Targeting of cancer neoantigens with donor-derived T cell receptor repertoires
Erlend Stronen et al.
SCIENCE (2016)
Revisiting Thymic Positive Selection and the Mature T Cell Repertoire for Antigen
Nienke Vrisekoop et al.
IMMUNITY (2014)
Molecular mimicry of MAGE-A6 and Mycoplasma penetrans HF-2 epitopes in the induction of antitumor CD8+ T-cell responses
Lazar Vujanovic et al.
ONCOIMMUNOLOGY (2014)
Different affinity windows for virus and cancer-specific T-cell receptors: Implications for therapeutic strategies
Milos Aleksic et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
A Single Autoimmune T Cell Receptor Recognizes More Than a Million Different Peptides
Linda Wooldridge et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Why must T cells be cross-reactive?
Andrew K. Sewell
NATURE REVIEWS IMMUNOLOGY (2012)
MAGE-A10 is a nuclear protein frequently expressed in high percentages of tumor cells in lung, skin and urothelial malignancies
Elke Schultz-Thater et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma
SA Rosenberg et al.
JOURNAL OF IMMUNOLOGY (2005)